Zelira Therapeutics (ASX:ZLD) - CEO and MD, Dr Oludare Odumosu
CEO and MD, Dr Oludare Odumosu
Source: Zelira Therapeutics
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Zelira Therapeutics (ZLD) receives formal approval from the German regulatory authority BfArM for the commercialisation of Zenivol in the country
  • This is a significant milestone for the company as it allows Zelira to expand the availability of Zenivol beyond Australia for the first time
  • Zenivol is a cannabinoid-based medicine used the treat chronic insomnia with a phase 1b/2a clinical trial showing it to be safe and effective
  • According to Managing Director Dr Oludare Odumosu, the company is continuing to progress activities to licence Zenivol in other markets
  • Shares in Zelira are up 13.1 per cent on market close, trading at $2.24 each

Zelira Therapeutics (ZLD) has received formal approval from the German regulatory authority BfArM for the commercialisation of Zenivol in the country.

This is a significant milestone for the company as it allows Zelira to expand the availability of Zenivol beyond Australia for the first time.

It also reinforces the pharmaceutical quality, safety and efficacy of Zenivol and Zelira’s other cannabinoid-based medicines.

Zenivol is a cannabinoid-based medicine used the treat chronic insomnia with a phase 1b/2a clinical trial showing it to be safe and effective.

“The formal approval of Zenivol by BfArM in Germany marks a major milestone for our business,” Managing Director Dr Oludare Odumosu commented.

“We look forward to working with our partner, Adjupharm in launching Zenivol in Germany and supporting patients and physicians in treating chronic insomnia in a safe and effective manner.

“With formal regulatory approval for Zenivol now received in Germany, we continue to progress activities to license Zenivol into other global markets.”

Shares in Zelira were up 13.1 per cent on market close and were trading at $2.24 each.

ZLD by the numbers
More From The Market Herald
The Market Herald Video

" Woomera Mining (ASX:WML) appoints Jason Livingstone as new Managing Director

Mineral explorer Woomera Mining (ASX:WML) has appointed Jason Livingstone as its new Managing Director, effective from…
The Market Herald Video

" Security Matters (ASX:SMX) enters into $2m standby equity facility

Security Matters (ASX:SMX) has entered into a standby equity deed with Evolution Capital.
The Market Herald Video

" Ora Gold (ASX:OAU) obtains unsecured $500k loan facility

Ora Gold (ASX:OAU) has obtained an unsecured $500,000 loan facility from Ioma to assist with general…
Baby Bunting (ASX:BBN) - Chair and Non Executive Director, Melanie Wilson

" Baby Bunting (ASX:BBN) surpasses $500m sales for the first time

Baby goods retailer Baby Bunting (ASX:BBN) surpasses half a billion dollars in sales for the first…